Jean-Mathieu Beauregard
Jean-Mathieu Beauregard
Associate Professor of Nuclear Medicine, Université Laval
Verified email at chudequebec.ca - Homepage
TitleCited byYear
Quantitative 177Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system
JM Beauregard, MS Hofman, JM Pereira, P Eu, RJ Hicks
Cancer Imaging 11 (1), 56-66, 2011
792011
68Ga PET/CT Ventilation-Perfusion Imaging for Pulmonary Embolism: A Pilot Study with Comparison to Conventional Scintigraphy
MS Hofman, JM Beauregard, TW Barber, OC Neels, P Eu, RJ Hicks
The Journal Of Nuclear Medicine 52 (10), 1513, 2011
632011
Pilot comparison of 18F‐fluorocholine and 18F‐fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer
JM Beauregard, SG Williams, TR DeGrado, P Roselt, RJ Hicks
Journal of medical imaging and radiation oncology 54 (4), 325-332, 2010
632010
The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy
JM Beauregard, MS Hofman, G Kong, RJ Hicks
European journal of nuclear medicine and molecular imaging 39 (1), 50-56, 2012
562012
Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non–small cell lung cancer
C Lasnon, RJ Hicks, JM Beauregard, A Milner, M Paciencia, AV Guizard, ...
Clinical nuclear medicine 37 (10), 971-976, 2012
452012
Clinical utility of amyloid PET imaging in the differential diagnosis of atypical dementias and its impact on caregivers
MR Bensaïdane, JM Beauregard, S Poulin, FA Buteau, J Guimond, ...
Journal of Alzheimer's Disease 52 (4), 1251-1262, 2016
352016
An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imaging
PA Jackson, JM Beauregard, MS Hofman, T Kron, A Hogg, RJ Hicks
Medical physics 40 (11), 112503, 2013
332013
Assessment of human biodistribution and dosimetry of 4-fluoro-11β-methoxy-16α-18F-fluoroestradiol using serial whole-body PET/CT
JM Beauregard, É Croteau, N Ahmed, JE van Lier, F Bénard
Journal of Nuclear Medicine 50 (1), 100-107, 2009
282009
High throughput static and dynamic small animal imaging using clinical PET/CT: potential preclinical applications
N Aide, C Desmonts, JM Beauregard, T Beyer, K Kinross, P Roselt, ...
European journal of nuclear medicine and molecular imaging 37 (5), 991-1001, 2010
272010
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
M Del Prete, FA Buteau, JM Beauregard
European journal of nuclear medicine and molecular imaging 44 (9), 1490-1500, 2017
222017
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumors: a simulation study
M Del Prete, FA Buteau, JM Beauregard
Endocrine Abstracts 47, OC13, 2016
222016
FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy
JM Beauregard, AC Blouin, V Fradet, A Caron, Y Fradet, C Lemay, ...
Cancer Imaging 15 (1), 2, 2015
222015
Rapid blood clearance and lack of long-term renal toxicity of 177Lu-DOTATATE enables shortening of renoprotective amino acid infusion
R Kashyap, P Jackson, MS Hofman, P Eu, JM Beauregard, D Zannino, ...
European journal of nuclear medicine and molecular imaging 40 (12), 1853-1860, 2013
222013
Accuracy of 177 Lu activity quantification in SPECT imaging: a phantom study
CF Uribe, PL Esquinas, J Tanguay, M Gonzalez, E Gaudin, ...
EJNMMI physics 4 (1), 2, 2017
212017
[18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour …
F Bénard, N Ahmed, JM Beauregard, J Rousseau, A Aliaga, C Dubuc, ...
European journal of nuclear medicine and molecular imaging 35 (8), 1473-1479, 2008
212008
Effective specific activities determined by scintillation proximity counting for production runs of [18F]FES and 4F-M[18F]FES
JM Beauregard, E Croteau, N Ahmed, R Ouellette, JE van Lier, F Bénard
Nuclear medicine and biology 34 (3), 325-329, 2007
112007
Steroid receptor imaging in breast cancer
JM Beauregard, É Turcotte, F Bénard
PET clinics 1 (1), 51-70, 2006
102006
New developments in the imaging of metastatic prostate cancer
JM Beauregard, F Pouliot
Current opinion in supportive and palliative care 8 (3), 265-270, 2014
82014
Metabolic imaging of prostate cancer reveals intrapatient intermetastasis response heterogeneity to systemic therapy
F Morin, JM Beauregard, M Bergeron, MN Makao, L Lacombe, V Fradet, ...
European urology focus 3 (6), 639-642, 2017
72017
Evaluation of a new visual uptake scoring scale for 18F-fluorothymidine positron emission tomography in the diagnosis of pulmonary lesions
JM Beauregard, AL Giraudet, N Aide, MS Hofman, R Blum, E Drummond, ...
Nuclear medicine communications 34 (6), 521-526, 2013
72013
The system can't perform the operation now. Try again later.
Articles 1–20